A detailed history of Gerber Kawasaki Wealth & Investment Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Gerber Kawasaki Wealth & Investment Management holds 1,864 shares of LLY stock, worth $1.69 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,864
Previous 1,926 3.22%
Holding current value
$1.69 Million
Previous $1.5 Million 12.62%
% of portfolio
0.09%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $44,941 - $56,360
-62 Reduced 3.22%
1,864 $1.69 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $5,922 - $7,922
10 Added 0.52%
1,926 $1.5 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $622,875 - $734,288
-1,186 Reduced 38.23%
1,916 $1.12 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $19,561 - $26,968
-45 Reduced 1.43%
3,102 $1.67 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $358,456 - $479,297
1,022 Added 48.09%
3,147 $1.48 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $19,880 - $23,348
-64 Reduced 2.92%
2,125 $729,000
Q4 2022

Feb 08, 2023

SELL
$321.55 - $374.67 $19,293 - $22,480
-60 Reduced 2.67%
2,189 $800,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $40,617 - $46,288
137 Added 6.49%
2,249 $727,000
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $33,168 - $38,945
-119 Reduced 5.33%
2,112 $684,000
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $96,926 - $120,455
-413 Reduced 15.62%
2,231 $638,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $21,585 - $26,787
96 Added 3.77%
2,644 $730,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $13,074 - $16,089
59 Added 2.37%
2,548 $588,000
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $5,055 - $6,539
-28 Reduced 1.11%
2,489 $571,000
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $413,593 - $535,416
2,517 New
2,517 $470,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gerber Kawasaki Wealth & Investment Management Portfolio

Follow Gerber Kawasaki Wealth & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.